SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Will there be an Influenza Pandemic in the winter 1998-99?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10PreviousNext  
From: BiotaBull3/5/2005 11:20:58 AM
   of 19
 
A Flu Pandemic is very likely to erupt in the near future - it's well overdue given the flu cycles of the last century. Several years ago, BIOTA Holdings Ltd of Australia [BTA] developed the highly effective anti-viral drug Relenza (Zanamavir). But their licensing partners GSK (Glaxo..) let them down, and instead the drug Tamiflu developed by Roche has succeeded phenomenally in the world-wide market. GSK are being sued by BTA for compensation. A recent (March 2005) announcement by the British government that they have ordered stockpile of Tamiflu for around GBP 200 Million (US$400 million) reflects the huge market potential for anti-flu drugs.

Meanwhile Relenza, which currently accounts for less than 1% of the world anti-flu drug, has been refined and developed further by BTA and is proven to act against Bird Flu virus as well.. In my opinion BTA will benefit immensely from the forthcoming vicious influenza pandemic! Currently the stock is trading @ AUD$0.44 (having a reached a speculative high of AUD$9.00 in 2001). By 2006 September I feel, in my opinion it should be trading at much higher levels again.

www.biota.au.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10PreviousNext